B
Bisichem
The biotechnology company focuses on identifying molecular drug targets for immuno-oncology and central nervous system therapies, specifically targeting cancer and Alzheimer's disease. By developing first-in-class anti-cancer and immunosuppressive drugs, the company aims to provide effective treatment options for patients with these conditions.
Traction –/10
성남시, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The biotechnology company focuses on identifying molecular drug targets for immuno-oncology and central nervous system therapies, specifically targeting cancer and Alzheimer's disease. By developing first-in-class anti-cancer and immunosuppressive drugs, the company aims to provide effective treatment options for patients with these conditions.